William Beck Lewis, MD
Otolaryngology · Emeryville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · University Healthcare Alliance
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lewis’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G86559 · Current
Licensed to practise in California · since 2002 · expires 2028-07-31 · State University of New York Health Science Center at Syracuse.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- The Surgery Center of Alta Bates Summit Medical CenterAmbulatory Surgery Center · Oakland, CAOwner · accredited by JCInitial Accreditation4 inspections, 4 with deficiencies · last 2017-07-27: Requirements Met
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$112,170
Medicare paid this office $112,170 for 651 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 407 | $51,111 | $88 |
| New patient visit (45+ min) | 133 | $14,807 | $111 |
| Short return visit (20+ min) | 188 | $14,256 | $57 |
| Removal of impacted ear wax | 176 | $6,145 | $26 |
| New patient visit (30+ min) | 68 | $4,956 | $73 |
See all 7 services
| Return visit (30+ min) | 407 | $51,111 | $88 |
| New patient visit (45+ min) | 133 | $14,807 | $111 |
| Short return visit (20+ min) | 188 | $14,256 | $57 |
| Removal of impacted ear wax | 176 | $6,145 | $26 |
| New patient visit (30+ min) | 68 | $4,956 | $73 |
| Diagnostic exam of voice box using a flexible endoscope | 47 | $4,020 | $73 |
| Diagnostic exam of nasal passages using an endoscope | 22 | $1,720 | $66 |
Who their Medicare patients are
651 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 13% · Women 59% · Also on Medicaid 15% · Health risk score 1.18. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 61% · Coronary heart disease 20% · Diabetes 19% · Chronic kidney disease 19% · Depression 18% · Cancer 16% · Atrial fibrillation 15% · COPD 11% · Heart failure 10% · Stroke 9% · Dementia 4%.
The office billed $480,737, Medicare allowed $153,063 and paid $112,170; for 1,437 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 651 | 1,437 | 76 | 1.18 | $480,737 | $112,170 |
| 2023 | 647 | 1,412 | 75 | 1.12 | $478,774 | $112,254 |
| 2022 | 674 | 1,454 | 75 | 1.19 | $425,056 | $110,288 |
| 2021 | 625 | 1,465 | 75 | 1.22 | $477,121 | $119,086 |
| 2020 | 469 | 1,101 | 74 | 1.37 | $401,054 | $76,896 |
| 2019 | 622 | 1,534 | 74 | 1.43 | $552,247 | $108,316 |
| 2018 | 730 | 2,764 | 72 | 1.44 | $711,638 | $162,620 |
| 2017 | 677 | 2,426 | 73 | 1.40 | $605,649 | $148,890 |
| 2016 | 673 | 2,637 | 73 | 1.28 | $604,276 | $152,629 |
| 2015 | 677 | 2,930 | 73 | 1.34 | $604,107 | $162,222 |
| 2014 | 616 | 3,145 | 73 | 1.25 | $310,279 | $146,356 |
| 2013 | 599 | 3,029 | 72 | 1.15 | $315,172 | $151,867 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 463 | $56,253 | $82 |
| New patient visit (45+ min) | 203 | $21,753 | $107 |
| Removal of impacted ear wax | 200 | $7,108 | $28 |
| Diagnostic exam of voice box using a flexible endoscope | 39 | $3,185 | $71 |
| Short return visit (20+ min) | 47 | $3,002 | $63 |
| Diagnostic exam of nasal passages using an endoscope | 40 | $1,696 | $39 |
| New patient visit (30+ min) | 18 | $1,379 | $77 |
2022: 7 services
| Return visit (30+ min) | 439 | $53,064 | $83 |
| New patient visit (45+ min) | 211 | $23,361 | $111 |
| Removal of impacted ear wax | 197 | $7,181 | $28 |
| Short return visit (20+ min) | 91 | $5,639 | $53 |
| New patient visit (30+ min) | 50 | $3,607 | $72 |
| Diagnostic exam of voice box using a flexible endoscope | 47 | $3,333 | $64 |
| Diagnostic exam of nasal passages using an endoscope | 49 | $1,548 | $29 |
2021: 7 services
| Return visit (30+ min) | 359 | $44,807 | $88 |
| New patient visit (45+ min) | 199 | $24,063 | $121 |
| Short return visit (20+ min) | 199 | $14,217 | $58 |
| New patient visit (30+ min) | 89 | $6,665 | $75 |
| Removal of impacted ear wax | 193 | $6,520 | $28 |
| Diagnostic exam of voice box using a flexible endoscope | 47 | $2,903 | $59 |
| Diagnostic exam of nasal passages using an endoscope | 39 | $1,225 | $27 |
2020: 9 services
| Return visit (30+ min) | 264 | $25,883 | $68 |
| New patient visit (45+ min) | 91 | $10,106 | $111 |
| Short return visit (20+ min) | 132 | $7,424 | $42 |
| New patient visit (30+ min) | 95 | $5,643 | $59 |
| Removal of impacted ear wax | 113 | $3,857 | $29 |
| Long return visit (40+ min) | 36 | $3,427 | $95 |
| Diagnostic exam of voice box using a flexible endoscope | 42 | $2,731 | $56 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $651 | $25 |
| Telehealth originating site facility fee | 15 | $320 | $20 |
2019: 9 services
| Short return visit (20+ min) | 296 | $24,668 | $55 |
| Return visit (30+ min) | 166 | $16,236 | $77 |
| New patient visit (30+ min) | 227 | $15,912 | $70 |
| Removal of impacted ear wax | 163 | $6,817 | $32 |
| Diagnostic exam of voice box using a flexible endoscope | 84 | $6,255 | $73 |
| New patient visit (45+ min) | 50 | $6,100 | $122 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $5,132 | $103 |
| Short return visit | 35 | $1,174 | $30 |
| New patient visit (15+ min) | 11 | $413 | $38 |
2018: 12 services
| Return visit (30+ min) | 277 | $33,269 | $89 |
| Short return visit (20+ min) | 293 | $25,132 | $61 |
| New patient visit (45+ min) | 170 | $21,049 | $124 |
| Diagnostic exam of nasal passages using an endoscope | 67 | $14,153 | $156 |
| New patient visit (30+ min) | 158 | $12,551 | $79 |
| Diagnostic exam of voice box using a flexible endoscope | 107 | $10,662 | $90 |
| Removal of impacted ear wax | 151 | $6,495 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,056 | $121 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 36 | $1,766 | $46 |
| Simple control of nose bleed | 15 | $1,751 | $103 |
| Professional service for multiple injections of allergen | 16 | $1,292 | $10 |
| Short return visit | 18 | $694 | $39 |
2017: 10 services
| Short return visit (20+ min) | 434 | $42,702 | $61 |
| New patient visit (30+ min) | 263 | $22,894 | $87 |
| Diagnostic exam of nasal passages using an endoscope | 53 | $14,417 | $190 |
| Diagnostic exam of voice box using a flexible endoscope | 96 | $11,050 | $98 |
| Removal of impacted ear wax | 149 | $7,361 | $39 |
| Return visit (30+ min) | 67 | $6,649 | $90 |
| New patient visit (45+ min) | 41 | $5,601 | $137 |
| Short return visit | 38 | $1,508 | $40 |
| Simple control of nose bleed | 15 | $1,355 | $80 |
| Professional service for multiple injections of allergen | 15 | $1,186 | $9 |
2016: 13 services
| Short return visit (20+ min) | 361 | $35,292 | $61 |
| New patient visit (30+ min) | 321 | $27,675 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 77 | $16,877 | $188 |
| Diagnostic exam of voice box using a flexible endoscope | 103 | $11,793 | $96 |
| Removal of impacted ear wax | 159 | $7,945 | $38 |
| Return visit (30+ min) | 50 | $5,843 | $91 |
| Professional service for preparation and provision of 1 or more antigens | 12 | $3,874 | $11 |
| Short return visit | 92 | $3,694 | $35 |
| New patient visit (45+ min) | 17 | $1,915 | $113 |
| New patient visit (15+ min) | 29 | $1,637 | $56 |
| Professional service for multiple injections of allergen | 17 | $1,420 | $9 |
| Simple control of nose bleed | 15 | $1,167 | $73 |
| Comprehensive hearing and speech recognition test | 14 | $480 | $32 |
2015: 14 services
| Short return visit (20+ min) | 409 | $40,616 | $62 |
| New patient visit (30+ min) | 344 | $30,022 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 115 | $14,687 | $101 |
| Diagnostic exam of nasal passages using an endoscope | 57 | $12,988 | $194 |
| Removal of impacted ear wax | 159 | $7,859 | $41 |
| Return visit (30+ min) | 30 | $2,999 | $94 |
| Professional service for multiple injections of allergen | 17 | $1,777 | $9 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,650 | $118 |
| Short return visit | 40 | $1,572 | $37 |
| Simple control of nose bleed | 16 | $1,430 | $79 |
| Comprehensive hearing and speech recognition test | 37 | $1,202 | $30 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 17 | $455 | $27 |
| Test for eardrum and muscle function | 24 | $431 | $17 |
| Test to assess middle ear function | 17 | $224 | $13 |
2014: 13 services
| New patient visit (30+ min) | 337 | $30,414 | $90 |
| Short return visit (20+ min) | 304 | $29,300 | $63 |
| Diagnostic exam of nasal passages using an endoscope | 60 | $14,823 | $193 |
| Diagnostic exam of voice box using a flexible endoscope | 113 | $14,675 | $101 |
| Removal of impacted ear wax | 135 | $7,202 | $41 |
| Test for allergy using allergenic extract | 12 | $5,706 | $6 |
| Professional service for multiple injections of allergen | 17 | $1,313 | $10 |
| Test for allergy using allergenic extract injected into skin | 11 | $1,274 | $7 |
| Injection of medication into nasal air passage | 12 | $1,249 | $96 |
| Return visit (30+ min) | 12 | $1,095 | $91 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 21 | $1,005 | $46 |
| Short return visit | 14 | $545 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $134 | None |
2013: 14 services
| Short return visit (20+ min) | 257 | $24,906 | $63 |
| New patient visit (30+ min) | 268 | $24,387 | $91 |
| Diagnostic exam of voice box using a flexible endoscope | 81 | $11,691 | $103 |
| Diagnostic exam of nasal passages using an endoscope | 42 | $11,455 | $201 |
| Removal of impacted ear wax | 143 | $7,600 | $43 |
| Test for allergy using allergenic extract | 11 | $5,443 | $6 |
| Short return visit | 93 | $4,842 | $39 |
| New patient visit (15+ min) | 53 | $3,248 | $61 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 51 | $2,564 | $48 |
| Return visit (30+ min) | 29 | $2,536 | $87 |
| Ultrasound scan of head and neck soft tissue | 12 | $1,433 | $119 |
| Simple control of nose bleed | 13 | $1,368 | $85 |
| Professional service for multiple injections of allergen | 16 | $1,308 | $9 |
| Exam of ear using a microscope | 35 | $1,203 | $29 |
Medicaid work
$390 in 2023
Medicaid paid $390 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $390 |
| 2023 | 13 | 1 | 13 | $390 |
| 2021 | 15 | 1 | 13 | $0 |
| 2020 | 18 | 1 | 18 | $0 |
| 2019 | 123 | 2 | 23 | $2,873 |
| 2018 | 346 | 5 | 30 | $11,279 |
See the largest Medicaid services in earlier years
2021
| Hospital outpatient clinic visit for assessment and management of a patient | 15 | $0 |
2020
| Hospital outpatient clinic visit for assessment and management of a patient | 18 | $0 |
2019
| Short return visit (20+ min) | 97 | $2,815 |
| Hospital outpatient clinic visit for assessment and management of a patient | 26 | $58 |
2018
| Return visit (30+ min) | 127 | $5,058 |
| New patient visit (45+ min) | 105 | $3,517 |
| Short return visit (20+ min) | 86 | $2,191 |
| Diagnostic flexible fiberoptic laryngoscopy | 14 | $382 |
| Removal of impacted ear wax | 14 | $131 |
Drugs they prescribed that Part D paid
$17,681
Pharmacies billed $17,681 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (23 of 518) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
495 generic and 23 brand-name prescriptions · $17,681 in drug cost · 38 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 177 | $5,810 | $33 |
| Ciprofloxacin-Dexamethasone | 20 | $2,333 | $117 |
| Fluocinolone Acetonide Oil | 35 | $1,750 | $50 |
| Mometasone Furoate | 24 | $1,337 | $56 |
| Ofloxacin | 34 | $1,267 | $37 |
See all 12 drugs
| Ipratropium | 177 | $5,810 | $33 |
| Ciprofloxacin-Dexamethasone | 20 | $2,333 | $117 |
| Fluocinolone Acetonide Oil | 35 | $1,750 | $50 |
| Mometasone Furoate | 24 | $1,337 | $56 |
| Ofloxacin | 34 | $1,267 | $37 |
| Azelastine | 36 | $1,008 | $28 |
| Fluticasone Propionate | 33 | $613 | $19 |
| Fluconazole | 11 | $229 | $21 |
| Hydrocodone-Acetaminophen | 22 | $184 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $131 | $12 |
| Prednisone | 15 | $71 | $5 |
| Mupirocin | 12 | $45 | $4 |
Year by year
| 2024 | 518 | 204 | 4% (23) | 4% | $17,681 |
| 2023 | 525 | 206 | 3% (16) | None | $20,993 |
| 2022 | 569 | 216 | 4% (20) | 6% | $24,523 |
| 2021 | 461 | 183 | 4% (20) | 7% | $17,463 |
| 2020 | 428 | 157 | 4% (16) | 11% | $25,664 |
| 2019 | 386 | 153 | 4% (15) | 10% | $21,853 |
| 2018 | 438 | 172 | 6% (26) | 16% | $30,685 |
| 2017 | 386 | 169 | 7% (28) | 15% | $26,932 |
| 2016 | 411 | 152 | 9% (35) | 33% | $42,408 |
| 2015 | 430 | 163 | 9% (37) | None | $32,464 |
| 2014 | 413 | 153 | 8% (32) | None | $34,789 |
| 2013 | 705 | 184 | 7% (52) | 27% | $45,345 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Ipratropium | 153 | $6,799 | $44 |
| Ciprofloxacin-Dexamethasone | 18 | $2,947 | $164 |
| Fluocinolone Acetonide Oil | 37 | $2,368 | $64 |
| Ofloxacin | 23 | $1,597 | $69 |
| Mometasone Furoate | 19 | $1,155 | $61 |
| Fluticasone Propionate | 58 | $824 | $14 |
| Azelastine | 21 | $697 | $33 |
| Mupirocin | 21 | $265 | $13 |
| Hydrocodone-Acetaminophen | 13 | $95 | $7 |
| Amoxicillin | 12 | $45 | $4 |
2022: 11 drugs
| Ipratropium | 176 | $7,714 | $44 |
| Ciprofloxacin-Dexamethasone | 25 | $4,310 | $172 |
| Ofloxacin | 32 | $1,730 | $54 |
| Fluocinolone Acetonide Oil | 24 | $1,582 | $66 |
| Mometasone Furoate | 20 | $1,556 | $78 |
| Azelastine | 23 | $1,159 | $50 |
| Fluticasone Propionate | 60 | $679 | $11 |
| Hydrocodone-Acetaminophen | 20 | $209 | $10 |
| Prednisone | 20 | $153 | $8 |
| Mupirocin | 16 | $147 | $9 |
| Azithromycin | 16 | $106 | $7 |
2021: 10 drugs
| Ipratropium | 83 | $3,285 | $40 |
| Azelastine-Fluticasone | 15 | $2,340 | $156 |
| Fluocinolone Acetonide Oil | 32 | $1,781 | $56 |
| Ofloxacin | 39 | $1,723 | $44 |
| Fluticasone Propionate | 78 | $1,157 | $15 |
| Mometasone Furoate | 15 | $931 | $62 |
| Azelastine | 15 | $568 | $38 |
| Fluconazole | 18 | $468 | $26 |
| Hydrocodone-Acetaminophen | 19 | $199 | $10 |
| Mupirocin | 11 | $86 | $8 |
2020: 14 drugs
| Ciprodex | 22 | $5,506 | $250 |
| Fluocinolone Acetonide Oil | 31 | $3,246 | $105 |
| Ipratropium | 50 | $2,007 | $40 |
| Azelastine-Fluticasone | 12 | $1,918 | $160 |
| Mometasone Furoate | 17 | $1,847 | $109 |
| Fluticasone Propionate | 83 | $1,816 | $22 |
| Ofloxacin | 29 | $1,020 | $35 |
| Azelastine | 14 | $567 | $40 |
| Hydrocodone-Acetaminophen | 16 | $330 | $21 |
| Amoxicillin-Clavulanate Potass | 14 | $248 | $18 |
| Omeprazole | 11 | $174 | $16 |
| Mupirocin | 16 | $147 | $9 |
| Azithromycin | 20 | $100 | $5 |
| Prednisone | 15 | $57 | $4 |
2019: 11 drugs
| Fluocinolone Acetonide Oil | 33 | $3,593 | $109 |
| Ofloxacin | 38 | $3,505 | $92 |
| Dymista | 16 | $3,216 | $201 |
| Mometasone Furoate | 12 | $1,323 | $110 |
| Fluticasone Propionate | 56 | $611 | $11 |
| Ipratropium | 16 | $544 | $34 |
| Amoxicillin-Clavulanate Potass | 12 | $171 | $14 |
| Mupirocin | 15 | $148 | $10 |
| Azithromycin | 22 | $135 | $6 |
| Hydrocodone-Acetaminophen | 13 | $118 | $9 |
| Prednisone | 17 | $101 | $6 |
2018: 11 drugs
| Ofloxacin | 52 | $6,096 | $117 |
| Ciprodex | 23 | $5,134 | $223 |
| Dymista | 23 | $4,792 | $208 |
| Fluocinolone Acetonide Oil | 15 | $1,987 | $132 |
| Fluticasone Propionate | 55 | $821 | $15 |
| Ipratropium | 18 | $500 | $28 |
| Hydrocodone-Acetaminophen | 22 | $195 | $9 |
| Azithromycin | 19 | $143 | $8 |
| Prednisone | 26 | $102 | $4 |
| Mupirocin | 11 | $81 | $7 |
| Hydrocortisone | 11 | $52 | $5 |
2017: 12 drugs
| Dymista | 14 | $3,455 | $247 |
| Ofloxacin | 25 | $3,420 | $137 |
| Fluocinolone Acetonide Oil | 15 | $2,370 | $158 |
| Ciprodex | 11 | $2,239 | $204 |
| Mometasone Furoate | 11 | $1,853 | $168 |
| Azelastine | 17 | $1,430 | $84 |
| Fluticasone Propionate | 59 | $1,191 | $20 |
| Flunisolide | 13 | $605 | $47 |
| Hydrocodone-Acetaminophen | 25 | $321 | $13 |
| Ipratropium | 14 | $209 | $15 |
| Azithromycin | 19 | $131 | $7 |
| Prednisone | 18 | $90 | $5 |
2016: 11 drugs
| Nasonex | 18 | $5,249 | $292 |
| Januvia | 12 | $4,470 | $372 |
| Fluocinolone Acetonide Oil | 22 | $3,753 | $171 |
| Cipro Hc | 13 | $3,377 | $260 |
| Zetia | 11 | $3,042 | $277 |
| Ciprodex | 12 | $2,289 | $191 |
| Fluticasone Propionate | 37 | $659 | $18 |
| Ofloxacin | 17 | $494 | $29 |
| Hydrocodone-Acetaminophen | 27 | $393 | $15 |
| Prednisone | 16 | $114 | $7 |
| Azithromycin | 18 | $102 | $6 |
2015: 12 drugs
| Nasonex | 23 | $4,997 | $217 |
| Januvia | 13 | $4,474 | $344 |
| Zetia | 12 | $2,895 | $241 |
| Ciprodex | 13 | $2,497 | $192 |
| Fluticasone Propionate | 50 | $761 | $15 |
| Ofloxacin | 22 | $706 | $32 |
| Hydrocodone-Acetaminophen | 34 | $307 | $9 |
| Neomycin-Polymyxin-Hydrocort | 14 | $275 | $20 |
| Atorvastatin | 14 | $259 | $19 |
| Azithromycin | 23 | $161 | $7 |
| Amoxicillin | 17 | $122 | $7 |
| Prednisone | 15 | $61 | $4 |
2014: 13 drugs
| Nasonex | 24 | $5,607 | $234 |
| Epipen 2-Pak | 15 | $5,115 | $341 |
| Januvia | 13 | $3,872 | $298 |
| Ciprodex | 16 | $2,518 | $157 |
| Zetia | 12 | $2,314 | $193 |
| Fluticasone Propionate | 32 | $711 | $22 |
| Triamcinolone Acetonide | 11 | $606 | $55 |
| Hydrocodone-Acetaminophen | 27 | $336 | $12 |
| Neomycin-Polymyxin-Hydrocort | 13 | $297 | $23 |
| Neomycin-Polymyxin-Hc | 13 | $286 | $22 |
| Atorvastatin | 13 | $231 | $18 |
| Azithromycin | 14 | $135 | $10 |
| Prednisone | 19 | $104 | $5 |
2013: 26 drugs
| Nasonex | 39 | $6,553 | $168 |
| Namenda | 13 | $3,509 | $270 |
| Januvia | 12 | $3,077 | $256 |
| Aggrenox | 11 | $2,995 | $272 |
| Ciprodex | 16 | $2,401 | $150 |
| Dymista | 16 | $2,337 | $146 |
| Benicar | 12 | $2,054 | $171 |
| Zetia | 12 | $1,954 | $163 |
| Neomycin-Polymyxin-Hc | 57 | $1,304 | $23 |
| Fluticasone Propionate | 31 | $1,018 | $33 |
| Hydrocodone-Acetaminophen | 46 | $904 | $20 |
| Atorvastatin | 23 | $650 | $28 |
| Metoprolol | 16 | $307 | $19 |
| Potassium Chloride | 11 | $301 | $27 |
| Ofloxacin | 15 | $285 | $19 |
| Finasteride | 12 | $280 | $23 |
| Amoxicillin | 31 | $252 | $8 |
| Azithromycin | 20 | $250 | $13 |
| Donepezil | 12 | $187 | $16 |
| Metoprolol | 11 | $160 | $15 |
| Metformin Hcl Er | 17 | $147 | $9 |
| Triamterene-Hctz | 15 | $141 | $9 |
| Glipizide | 14 | $124 | $9 |
| Tamsulosin | 11 | $119 | $11 |
| Simvastatin | 12 | $67 | $6 |
| Prednisone | 12 | $43 | $4 |
Money from drug and device companies
$39 in 2022
| 2022 | 1 | 2 | None | $39 |
| 2021 | 1 | 1 | None | $18 |
| 2019 | 1 | 2 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Xpress Ent Dilation System | $39 | 2 payments
|
See all 2 published payments
| Stryker | Meals · 2022-06-30 | Xpress Ent Dilation System | $21 |
| Stryker | Meals · 2022-05-04 | Latera | $18 |
See earlier years (2021, 2019)
2021: $18
| Stryker | Xpress Ent Dilation System | $18 | 1 payment
|
2019: $116
| Stryker | Entellus - Xpress Office Start-Up Kits | $116 | 2 payments
|
Professional record
- NPI
- 1124081112
- Licence
- CA G86559California G86559: Current · expires 2028-07-31
- Trained
- State University of Ny Upstate Medical University, 1993
- Group
- Stanford Health Care · University Healthcare Alliance
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G865590
- Taxonomy
- Otolaryngology (207Y00000X); Federal specialty code 207YX0901X (207YX0901X)
- Mailing address
- 2961 Summit St, Suite 1, Oakland, CA, 94609
- NPI first listed
- 2006-04-10
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305